Related Experiment Video
Updated: Jun 28, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Inside the medicine cabinet: making children's medicines a grown-up issue
1Elizabeth Glaser Pediatric AIDS Foundation, 1140 Connecticut Avenue NW, Suite 200, Washington, District of Columbia 20036, USA. pedmed@pedaids.org
Insights
Children require specialized medicines, but many drugs lack pediatric data, especially antiretrovirals for pediatric HIV/AIDS. Global efforts must improve access to safe and effective pediatric medications, particularly in underserved regions.
Area of Science:
- Pediatric pharmacology
- Global health equity
- Antiretroviral drug development
Background:
- Most medicines lack specific pediatric formulation and clinical data.
- Children, especially those with HIV/AIDS, face limited access to appropriate drugs.
- Existing pediatric drug testing laws show recent improvements but are insufficient.
Purpose of the Study:
- To highlight the critical need for pediatric-specific medicines.
- To emphasize the disparities in access to antiretroviral drugs for children with HIV/AIDS.
- To advocate for enhanced global access to pediatric AIDS medicines.
Main Methods:
- Review of current pediatric drug formulation and testing regulations.
- Analysis of access to antiretroviral drugs for pediatric HIV/AIDS.
- Examination of global disparities in pediatric medicine availability.
Main Results:
- Significant lack of pediatric-tested and approved medications across therapeutic areas.
- Severe limitations in access to pediatric antiretroviral therapies for HIV/AIDS.
- Disproportionate impact on children in resource-poor countries.
Conclusions:
- Urgent need for increased development and approval of pediatric-specific drugs.
- Policy and regulatory enhancements are crucial for pediatric drug access.
- Global collaboration is essential to ensure equitable access to lifesaving medicines for children, particularly those with HIV/AIDS.
Abstract:
Children need medicines that are properly designed and formulated specifically for pediatric use. However, the majority of medicines prescribed for children have insufficient clinical data to support pediatric use or to determine how children will react to such medicines. In particular, children living with HIV/AIDS have limited access to pediatric-specific antiretroviral drugs used to fight the disease. Recent improvements to U.S. and European pediatric drug testing laws may help generate more drugs tested and approved for children, but more must be done to ensure that children do not lag behind in access to lifesaving AIDS medicines, particularly in resource-poor countries.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Infants and Children
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Factors Affecting Drug Response: Overview
Prevention of Further Absorption of Poison

